A Double Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Androgel, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes

Solvay Pharmaceuticals72 个研究点分布在 1 个国家开始时间: 2004年10月最近更新: 2015年1月21日

适应症

试验速览

阶段: 2 期
状态: 已完成
发起方: Solvay Pharmaceuticals
试验地点: 72

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is to investigate how well Androgel, when tested against placebo gel, helps to control blood sugar levels in males with type 2 diabetes who have low testosterone (the main male hormone) blood levels and are taking oral diabetic medicines alone or in combination with insulin.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double

入排标准

年龄范围: 30 Years 至 80 Years（Adult, Older Adult）
性别: Male
接受健康志愿者: 否

入选标准

•Able to read and write
•Between 30-80 years old
•Have type 2 diabetes
•Diagnoses of hypogonadism or low testosterone

排除标准

•On insulin monotherapy
•Use of testosterone therapy within the last 6 months
•Male breast cancer
•History of prostate cancer
•History of clinically significant sleep apnea

研究者

发起方

Solvay Pharmaceuticals

申办方类型

Industry

研究点 (72)

Loading locations...

相似试验

已完成

4 期

AndroGel in Men With Major Depression and Incomplete Response to Antidepressant TreatmentDepressive Disorder, Major

NCT00304746Mclean Hospital100

尚未招募

2 期

Effect of Pregabalin Gel in Controlling Cervical Dentin HypersensitivityDentin Sensitivity

NCT06417580Jesuína Lamartine Nogueira Araújo18

进行中（未招募）

3 期

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyProstatic Neoplasms

NCT03767244Janssen Research & Development, LLC2,517

已完成

1 期

Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep ApneaObstructive Sleep ApneaHealthy Subjects

NCT03471871Eisai Inc.146

终止

3 期

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV NeuropathyNeuropathy

NCT01049217Pfizer's Upjohn has merged with Mylan to form Viatris Inc.377